3,196
+0.06%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Medipal Holdings
Its shares trade on Tokyo Stock Exchange under the ticker 7459.T. It has been listed since 14 September 1995. In the fiscal year to 31 March 2026, it reported revenue of ¥3.82trn and net income of ¥42.53bn. At that date it held total assets of ¥1.92trn and shareholders' equity of ¥652.17bn.
Medipal Holdings Corp. manages its group companies which are engaged in the sale of pharmaceuticals, cosmetics, and daily necessities. The company is headquartered in Chuo-Ku, Tokyo-To. The firm operates in three segments. The Ethical Pharmaceutical Wholesale segment is involved in the wholesale of pharmaceutical products, medical equipment and test reagents, the distribution and planning of specialty drugs, the construction of medical material database and others. The Cosmetics, Daily Product and General Medicine Wholesale segment is engaged in the wholesale of cosmetics, daily miscellaneous goods and general pharmaceuticals. The Veterinary Medicine and Food Processing Raw Materials Wholesale segment is engaged in the wholesale of veterinary products, food additives and food raw materials. The firm is also involved in the provision of cleaning services, the management and operation of logistics centers, the provision of manpower dispatching services and others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 14 Sept 1995
- Employees
- 13,599
- Website
- medipal.co.jp ↗
Leadership
Pay as last reported
- Mr. Shuichi WatanabePresident, Chief Executive Officer, Representative Director, since 2007
- Mr. Hiroshi YarimizuSenior Managing Executive Officer, Deputy Chief Director of Administration, Director of Finance and Accounting
- Mr. Nobuhito YanaiExecutive Officer, Deputy Chief Director of Administration, Director of Finance and Accounting in Main Administration Unit
- Mr. Kuniaki ImagawaPresident of Subsidiary, Director, since 2012
- Mr. Koichi MimuraChairman of Subsidiary, Director, since 2020
- Mr. Shinjiro WatanabePresident of Subsidiary, Director, since 2013
- Mr. Yasuhiro ChofukuVice President, Chairman of Subsidiary, Director, since 2004
- Mr. Toshihide YodaSenior Managing Director, Chief Director of Business Development, since 2010
- Mr. Yuji SakonManaging Director, Chief Director of Administration, since 2012
- Mr. Yoshitaka IchiyanagiExecutive Officer, President of Subsidiary
- Mr. Mitsuhiro KyogokuExecutive Officer, Deputy Chief Director of Administration
- Mr. Yasuhiko SugimoriExecutive Officer, Deputy Chief Director of Main Business Development Unit, Director of Business Development
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 38
- Environment
- 48
- Social
- 53
- Governance
- 14
- Direct emissions (scope 1)
- 31,081 t
- Energy emissions (scope 2)
- 42,494 t
- Value chain emissions (scope 3)
- 219,650 t
- Women in the workforce
- 33.7%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Medipal Holdings Corp has several key strengths that contribute to its success. Firstly, the company operates a highly efficient supply chain, ensuring timely delivery and availability of medical products. Secondly, Medipal Holdings Corp holds a strong market position, with a diverse portfolio of healthcare products and services. This enables the company to serve a wide customer base and enjoy a competitive edge. Finally, the company has a well-established brand image and reputation, built on years of providing high-quality healthcare solutions.
Weaknesses
- Medipal Holdings Corp also faces certain weaknesses that require attention. The company heavily relies on external suppliers for its products, which exposes it to potential supply chain disruptions. Additionally, as a global healthcare provider, Medipal Holdings Corp may struggle with adapting to different regulatory environments and compliance requirements in various markets. Finally, the company's rapid expansion has led to increased complexity in its operations, requiring effective management and oversight.
Opportunities
- Medipal Holdings Corp has identified several opportunities for growth and development. Firstly, the increasing demand for healthcare products and services presents an opportunity for the company to expand its customer base and revenue streams. Secondly, the growing digital healthcare market offers avenues for Medipal Holdings Corp to innovate and offer new technology-driven solutions. Additionally, the company can explore strategic partnerships, acquisitions, or collaborations to enhance its offerings and enter new markets.
Threats
- Medipal Holdings Corp is not immune to potential threats in its operating environment. Firstly, intense competition from both established players and emerging startups poses a challenge to the company's market share. Secondly, geopolitical tensions and trade disputes can impact Medipal Holdings Corp's international operations and supply chain. Furthermore, changes in healthcare policies and regulations, as well as shifts in consumer preferences, can also pose threats to the company's growth and profitability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.